Trial Profile
Safety and efficacy of tolcapone in patients with Parkinson disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 19 Nov 2015 New trial record